The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Hanlon Suzanne M. since 2016.
The trader's CIK number is 1631682.
At the time of the last reporting, Hanlon Suzanne M. was the Sec, General Counsel & VP HR of Zynerba Pharmaceuticals, Inc.. (stock ticker symbol ZYNE).
Also see all insider trading activities at Zynerba Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | ZYNE | 3,800 | $22,047 | 0 | $0 | 0 | $0 |
| 2016 | ZYNE | 3,000 | $53,760 | 3,000 | $31,589 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-08-06 | ZYNE | Buy | 3,800 | 5.80 | 22,047 |
| 2016-08-16 | ZYNE | Sale | 3,000 | 10.53 | 31,589 |
| 2015-08-05 | ZYNE | Buy | 3,000 | 17.92 | 53,760 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hanlon Suzanne M. (Sec, General Counsel & VP HR of Zynerba Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.